HYPOPhosphatemia in the Intensive Care: A One-day Point Prevalence Survey

Completed

• Conditions: Critically Ill

• Registration Number: NCT04201899
• Lead Sponsor: Centre Hospitalier Universitaire Vaudois

Brief Summary

The point prevalence survey aims at defining the until now unknown real prevalence of hypophosphatemia (defined as blood phosphate value \< 0.8 mmol/l) in international critical care settings

Detailed Description

The survey will be conducted on one single day in each centre (D-day), within a week defined by the project coordinator (International PI). On D-Day, the local investigators will be asked

1. to complete questions aiming at describing their ICU (number of beds, number of patients present on D-Day, type medical/surgical/other, local phosphate reference value, presence of an hypophosphatemia treatment protocol in the ICU and route of phosphate delivery in case of hypophosphatemia)

2. to indicate how many patients had a blood phosphate \<0.08 mmol/l, for each patient with hypophosphatemia, to record the exact lowest value on D-Day, and to record age, number of days in ICU on D-Day, presence (or not) of artificial nutrition and continuous renal replacement therapy, if any phosphate administration is ongoing Data will be recorded in and electronic Case Report Form (e-CRF) in REDCap, and analysed with descriptive statistics No outcome data will be recorded (pure point-prevalence) There is no intervention

Study Timeline

• Study First Submitted: 2019-12-14
• Study First Submitted QC: 2019-12-16
• Study First Posted: 2019-12-17
• Study Start: 2020-03-09
• Primary Completion: 2020-07-31
• Study Completion: 2020-07-31
• Status Verified: 2021-01
• Last Update Submitted: 2021-01-31
• Last Update Posted: 2021-02-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 890

Inclusion Criteria

blood phosphate value < 0.8 mmol -

Exclusion Criteria

Blood phosphate value >0.8 mmol/l

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of hypophosphatemia	1 day	Blood value \< 0.8 mmol/l

Trial Locations

Locations (4)

Tartu University Hospital; 🇪🇪 Tartu, Estonia

Lausanne University Hospital; 🇨🇭 Lausanne, VD, Switzerland

Hôpital de Nyon; 🇨🇭 Nyon, Switzerland

Hôpital Pasteur 2; 🇫🇷 Nice, France